ZIKALIVAX 2.0 (Q3712907)

From EU Knowledge Graph
Revision as of 14:04, 27 November 2021 by DG Regio (talk | contribs) (‎Removed claim: summary (P836): Les travaux menés par le post-doctorant visent à valider expérimentalement la souche virale atténuée ZIKALIVax comme un candidat vaccin vivant contre la fièvre ZIKA., Removing translation)
Jump to navigation Jump to search
Project Q3712907 in France
Language Label Description Also known as
English
ZIKALIVAX 2.0
Project Q3712907 in France

    Statements

    country
    France
    0 references
    EU contribution
    63,811.94 Euro
    0 references
    budget
    99,706.15 Euro
    0 references
    co-financing rate
    64.0 percent
    0 references
    start time
    1 September 2017
    0 references
    end time
    31 August 2019
    0 references
    beneficiary name (string)
    UNIVERSITÉ DE LA RÉUNION
    0 references
    beneficiary
    Q3775809
    0 references
    summary
    Les travaux menés par le post-doctorant visent à valider expérimentalement la souche virale atténuée ZIKALIVax comme un candidat vaccin vivant contre la fièvre ZIKA. (French)
    0 references
    The postdoctoral research aims at experimentally validating the attenuated viral strain ZIKALIVax as a live vaccine candidate against ZIKA fever. (English)
    point in time
    22 November 2021
    0 references

    Identifiers

    French Kohesio ID
    RE0012406
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q3712907&oldid=16409916"